Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel
Andres Y. Maldonado

Andres Y. Maldonado Analyst Performance

Biotechnology Equity Research Analyst at HC Wainwright

Andres Y. Maldonado is a stock analyst at HC Wainwright in the healthcare sector, covering 29 publicly traded companies. Over the past year, Andres Y. Maldonado has issued 81 stock ratings, including strong buy, buy, and hold recommendations. While full access to Andres Y. Maldonado's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andres Y. Maldonado's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
136 Last 4 Years
Buy Recommendations
95.56% 129 Buy Ratings
Companies Covered
29 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.7%1 ratings
Buy94.8%128 ratings
Hold4.4%6 ratings
Sell0.0%0 ratings

Out of 135 total stock ratings issued by Andres Y. Maldonado at HC Wainwright, the majority (94.8%) have been Buy recommendations, followed by 4.4% Hold and 0.7% Strong Buy.

Best & Worst Calls

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
29 companies

Andres Y. Maldonado, an analyst at HC Wainwright, currently covers 29 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
29 companies		100.0%

Andres Y. Maldonado of HC Wainwright specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
26 companies		89.7%
PHARMACEUTICALS
3 companies		10.3%

Andres Y. Maldonado's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
Export
CompanyReport DateActionReport Date Price12-Month
Price Target		Rating12-Month
Price & ROI		Details
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
9/15/2026Boost Price Target$51.85$70.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
9/14/2026Reiterated Rating$8.34$35.00Buy
Verastem, Inc. stock logo
VSTM
Verastem
9/11/2026Reiterated Rating$7.41$18.00Buy
Immunome, Inc. stock logo
IMNM
Immunome
9/10/2026Reiterated Rating$25.65$40.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
9/8/2026Downgrade$56.83Neutral
enGene Holdings Inc. stock logo
ENGN
enGene
9/8/2026Reiterated Rating$1.89$4.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
9/8/2026Reiterated Rating$55.33$65.00Buy
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
9/8/2026Downgrade$0.39$1.00Neutral
Immuneering Corporation stock logo
IMRX
Immuneering
8/27/2026Reiterated Rating$5.15Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
8/26/2026Reiterated Rating$11.31$35.00Buy
I-Mab stock logo
NBP
I-Mab
8/20/2026Reiterated Rating$1.82$9.00Buy
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
8/13/2026Reiterated Rating$11.08$23.00Buy
Erasca, Inc. stock logo
ERAS
Erasca
8/12/2026Boost Price Target$18.31$22.00Buy
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
8/12/2026Reiterated Rating$0.76Buy
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
8/11/2026Lower Price Target$7.75$18.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
8/10/2026Reiterated Rating$52.92$65.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
8/7/2026Lower Price Target$9.74$35.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
8/6/2026Initiated Coverage$4.39$14.00Buy
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
8/5/2026Lower Price Target$19.08$38.00Buy
CG Oncology, Inc. stock logo
CGON
CG Oncology
7/29/2026Reiterated Rating$72.62$100.00Buy
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
7/22/2026Boost Price Target$112.57$125.00Buy
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
7/15/2026Reiterated Rating$24.13$40.00Buy
Erasca, Inc. stock logo
ERAS
Erasca
7/14/2026Reiterated Rating$17.90Buy
Immunome, Inc. stock logo
IMNM
Immunome
7/9/2026Reiterated Rating$24.01Buy
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
6/29/2026Reiterated Rating$87.68$105.00Buy
Verastem, Inc. stock logo
VSTM
Verastem
6/24/2026Reiterated Rating$4.21$18.00Buy
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
6/18/2026Initiated Coverage$6.60$12.00Buy
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
6/18/2026Initiated Coverage$6.73$12.00Buy
enGene Holdings Inc. stock logo
ENGN
enGene
6/16/2026Lower Price Target$1.77$4.00Buy
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
6/12/2026Reiterated Rating$17.91$40.00Buy
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
6/3/2026Reiterated Rating$18.39$40.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
6/2/2026Reiterated Rating$7.24$15.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
5/26/2026Reiterated Rating$8.30$40.00Buy
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
5/22/2026Reiterated Rating$19.77$40.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
5/20/2026Reiterated Rating$7.76$15.00Buy
CG Oncology, Inc. stock logo
CGON
CG Oncology
5/18/2026Reiterated Rating$66.93$100.00Buy
Sutro Biopharma, Inc. stock logo
STRO
Sutro Biopharma
5/15/2026Boost Price Target$38.42$50.00Buy
Immunome, Inc. stock logo
IMNM
Immunome
5/13/2026Reiterated Rating$22.69$40.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
5/8/2026Boost Price Target$46.45$65.00Buy
enGene Holdings Inc. stock logo
ENGN
enGene
5/8/2026Lower Price Target$1.72$6.00Buy
CODE RED: AI Meltdown Imminent? (Ad)

After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.tc pixel

See the five simple steps to prepare before it's too late
Verastem, Inc. stock logo
VSTM
Verastem
4/10/2026Reiterated Rating$5.38$18.00Buy
I-Mab stock logo
NBP
I-Mab
4/8/2026Reiterated Rating$2.48$9.00Buy
CG Oncology, Inc. stock logo
CGON
CG Oncology
4/7/2026Boost Price Target$67.55$100.00Buy
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
3/30/2026Reiterated Rating$6.31$22.00Buy
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
3/25/2026Reiterated Rating$52.76$53.00Neutral
Sutro Biopharma, Inc. stock logo
STRO
Sutro Biopharma
3/24/2026Upgrade$21.33$28.00Buy
I-Mab stock logo
NBP
I-Mab
3/16/2026Reiterated Rating$2.85$9.00Buy
Erasca, Inc. stock logo
ERAS
Erasca
3/13/2026Boost Price Target$14.65$20.00Buy
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
3/10/2026Reiterated Rating$5.48$13.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
3/10/2026Reiterated Rating$21.33$21.50Neutral
enGene Holdings Inc. stock logo
ENGN
enGene
3/9/2026Reiterated Rating$7.38$25.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
3/3/2026Reiterated Rating$45.83$58.00Buy
CG Oncology, Inc. stock logo
CGON
CG Oncology
2/27/2026Boost Price Target$59.09$80.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
2/25/2026Lower Price Target$12.02$22.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
2/23/2026Boost Price Target$9.81$15.00Buy
Immunome, Inc. stock logo
IMNM
Immunome
2/12/2026Initiated Coverage$23.41$40.00Buy
Immunome, Inc. stock logo
IMNM
Immunome
2/12/2026Initiated Coverage$22.44$40.00Buy
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
2/10/2026Reiterated Rating$6.48$23.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
1/26/2026Boost Price Target$44.29$58.00Buy
Erasca, Inc. stock logo
ERAS
Erasca
1/26/2026Boost Price Target$9.96$15.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
1/26/2026Boost Price Target$6.45$10.00Buy
Erasca, Inc. stock logo
ERAS
Erasca
1/13/2026Boost Price Target$6.23$11.00Buy
Sutro Biopharma, Inc. stock logo
STRO
Sutro Biopharma
12/22/2025Boost Price Target$9.98$10.00Neutral
Werewolf Therapeutics, Inc. stock logo
HOWL
Werewolf Therapeutics
12/19/2025Lower Price Target$0.65$4.00Buy
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
12/9/2025Boost Price Target$40.23$60.00Buy
enGene Holdings Inc. stock logo
ENGN
enGene
12/3/2025Reiterated Rating$7.86$25.00Buy
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
12/3/2025Reiterated Rating$6.71$23.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
11/24/2025Reiterated Rating$9.03$25.00Buy
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
11/19/2025Reiterated Rating$6.21$23.00Buy
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
11/13/2025Lower Price Target$1.19$7.00Buy
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
11/4/2025Upgrade$14.03$20.00Buy
I-Mab Sponsored ADR stock logo
IMAB
I-Mab
10/27/2025Reiterated Rating$4.53$7.00Buy
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
10/27/2025Reiterated Rating$13.53$40.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
10/20/2025Reiterated Rating$19.32$40.00Buy
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
10/16/2025Initiated Coverage$15.04$40.00Buy
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
10/15/2025Upgrade$15.05Strong-Buy
Merus N.V. stock logo
MRUS
Merus
9/29/2025Downgrade$93.71$97.00Neutral
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
9/29/2025Set Price Target$76.63$105.00Buy
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
9/29/2025Reiterated Rating$5.38$23.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
9/25/2025Boost Price Target$58.04$95.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
9/23/2025Lower Price Target$32.37$44.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
9/17/2025Reiterated Rating$10.27$40.00Buy
CG Oncology, Inc. stock logo
CGON
CG Oncology
9/15/2025Reiterated Rating$33.34$75.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
9/10/2025Reiterated Rating$2.57$8.00Buy
enGene Holdings Inc. stock logo
ENGN
enGene
9/8/2025Reiterated Rating$5.18$25.00Buy
CG Oncology, Inc. stock logo
CGON
CG Oncology
9/5/2025Reiterated Rating$32.52$75.00Buy
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
8/26/2025Initiated Coverage$30.42$70.00Buy
I-Mab Sponsored ADR stock logo
IMAB
I-Mab
8/21/2025Reiterated Rating$4.52$7.00Buy
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
8/13/2025Reiterated Rating$7.21$22.00Buy
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
8/8/2025Lower Price Target$13.36$20.00Buy
My top 3 AI picks for the next decade (Ad)

Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel

Click here to get all three AI stock names from Alexander Green
I-Mab Sponsored ADR stock logo
IMAB
I-Mab
7/9/2025Reiterated Rating$2.20$7.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
6/4/2025Reiterated Rating$2.71$8.00Buy
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
5/28/2025Upgrade$5.99$22.00Buy
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
5/15/2025Reiterated Rating$1.19$10.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
5/12/2025Reiterated Rating$2.28$8.00Buy
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
5/7/2025Lower Price Target$1.36$10.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
5/7/2025Lower Price Target$6.25$40.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
5/5/2025Reiterated Rating$2.10Buy
Erasca, Inc. stock logo
ERAS
Erasca
4/30/2025Reiterated Rating$1.43$6.00Buy
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
4/30/2025Reiterated Rating$4.25$13.00Buy
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
4/28/2025Reiterated Rating$4.32$23.00Buy
CG Oncology, Inc. stock logo
CGON
CG Oncology
4/28/2025Reiterated Rating$22.37$75.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
4/28/2025Reiterated Rating$2.59$8.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
4/16/2025Reiterated Rating$2.78$8.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
4/3/2025Reiterated Rating$7.97$36.00Buy
CG Oncology, Inc. stock logo
CGON
CG Oncology
3/31/2025Reiterated Rating$26.42$75.00Buy
Mural Oncology PLC stock logo
MURA
Mural Oncology
3/26/2025Lower Price Target$1.47$6.00Buy
CG Oncology, Inc. stock logo
CGON
CG Oncology
3/25/2025Reiterated Rating$28.53$75.00Buy
Erasca, Inc. stock logo
ERAS
Erasca
3/21/2025Reiterated Rating$1.48$6.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
3/13/2025Reiterated Rating$2.91$8.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
3/12/2025Reiterated Rating$6.88$50.00Buy
Werewolf Therapeutics, Inc. stock logo
HOWL
Werewolf Therapeutics
3/12/2025Reiterated Rating$1.26$15.00Buy
Mural Oncology PLC stock logo
MURA
Mural Oncology
3/12/2025Reiterated Rating$3.80$18.00Buy
enGene Holdings Inc. stock logo
ENGN
enGene
3/11/2025Reiterated Rating$5.24$25.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
2/26/2025Lower Price Target$11.82$36.00Buy
enGene Holdings Inc. stock logo
ENGN
enGene
12/23/2024Initiated Coverage$5.83$25.00Buy
Mural Oncology PLC stock logo
MURA
Mural Oncology
11/11/2024Reiterated Rating$3.52$18.00Buy
Mural Oncology PLC stock logo
MURA
Mural Oncology
10/17/2024Initiated Coverage$3.72$18.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
9/23/2024Reiterated Rating$19.51$80.00Buy

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Top Stock Recommendations by Brokerage